MONTELUKAST SODIUM

MONTELUKAST SODIUM was reported 123348 times

These side effects are most commonly reported by patients taking MONTELUKAST SODIUM:

# Side effect Count
0 ASTHMA 15205
1 DYSPNOEA 15084
2 DRUG INEFFECTIVE 9422
3 COUGH 9228
4 FATIGUE 8837
5 HEADACHE 8389
6 WHEEZING 7763
7 PNEUMONIA 7167
8 NAUSEA 6920
9 PAIN 6688
10 MALAISE 5385
11 DIZZINESS 4955
12 DIARRHOEA 4945
13 ANXIETY 4881
14 OFF LABEL USE 4790
15 VOMITING 4660
16 PRURITUS 4640
17 ARTHRALGIA 4335
18 PYREXIA 4112
19 RASH 4085
20 SINUSITIS 4066
21 DEPRESSION 3996
22 INSOMNIA 3777
23 WEIGHT DECREASED 3746
24 CHEST DISCOMFORT 3667
25 NASOPHARYNGITIS 3595
26 FALL 3521
27 HYPERSENSITIVITY 3423
28 DRUG HYPERSENSITIVITY 3399
29 ASTHENIA 3392
30 URTICARIA 3377
31 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3368
32 PRODUCT DOSE OMISSION ISSUE 3267
33 PAIN IN EXTREMITY 3259
34 CONDITION AGGRAVATED 3201
35 HYPERTENSION 3172
36 BACK PAIN 3083
37 PRODUCTIVE COUGH 3062
38 WEIGHT INCREASED 3034
39 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2952
40 BRONCHITIS 2910
41 CHEST PAIN 2840
42 FEELING ABNORMAL 2605
43 INFLUENZA 2485
44 PRODUCT USE IN UNAPPROVED INDICATION 2482
45 INJECTION SITE PAIN 2472
46 GASTROOESOPHAGEAL REFLUX DISEASE 2462
47 OBSTRUCTIVE AIRWAYS DISORDER 2423
48 BLOOD PRESSURE INCREASED 2400
49 UPPER RESPIRATORY TRACT INFECTION 2332
50 NASAL CONGESTION 2325
51 COVID-19 2295
52 CONSTIPATION 2270
53 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2267
54 ERYTHEMA 2243
55 SUICIDAL IDEATION 2196
56 DEATH 2161
57 ABDOMINAL PAIN 2136
58 MUSCLE SPASMS 2085
59 ABDOMINAL PAIN UPPER 2083
60 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2035
61 OROPHARYNGEAL PAIN 2012
62 URINARY TRACT INFECTION 1989
63 INFECTION 1956
64 TREMOR 1930
65 RHINORRHOEA 1868
66 SOMNOLENCE 1868
67 GAIT DISTURBANCE 1818
68 MYALGIA 1814
69 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1806
70 PRODUCT USE ISSUE 1776
71 ILLNESS 1767
72 HEART RATE INCREASED 1741
73 PERIPHERAL SWELLING 1723
74 HYPERHIDROSIS 1716
75 DYSPNOEA EXERTIONAL 1693
76 DECREASED APPETITE 1688
77 OEDEMA PERIPHERAL 1669
78 MIGRAINE 1627
79 FULL BLOOD COUNT ABNORMAL 1624
80 PARAESTHESIA 1599
81 SLEEP DISORDER 1589
82 DYSPHONIA 1571
83 HYPOAESTHESIA 1561
84 AGGRESSION 1548
85 ABDOMINAL DISCOMFORT 1538
86 PRODUCT QUALITY ISSUE 1512
87 SPUTUM DISCOLOURED 1463
88 ALOPECIA 1431
89 PALPITATIONS 1409
90 RESPIRATORY TRACT INFECTION 1393
91 INCORRECT DOSE ADMINISTERED 1349
92 HYPOTENSION 1346
93 JOINT SWELLING 1328
94 CONTUSION 1325
95 LOWER RESPIRATORY TRACT INFECTION 1306
96 OEDEMA 1306
97 ABNORMAL BEHAVIOUR 1301
98 CHILLS 1262
99 LUNG DISORDER 1248
100 STRESS 1232
101 RHEUMATOID ARTHRITIS 1222
102 VISION BLURRED 1205
103 DRUG DOSE OMISSION 1204
104 ANAEMIA 1199
105 MEMORY IMPAIRMENT 1184
106 BLOOD COUNT ABNORMAL 1176
107 MIDDLE INSOMNIA 1164
108 ANAPHYLACTIC REACTION 1160
109 OVERDOSE 1160
110 SEASONAL ALLERGY 1159
111 HOSPITALISATION 1157
112 PULMONARY EMBOLISM 1150
113 RENAL FAILURE 1147
114 SLEEP APNOEA SYNDROME 1141
115 SWELLING 1141
116 FLUSHING 1123
117 CHRONIC KIDNEY DISEASE 1118
118 DYSPEPSIA 1118
119 NIGHTMARE 1111
120 HEPATIC ENZYME INCREASED 1106
121 OXYGEN SATURATION DECREASED 1103
122 LOSS OF CONSCIOUSNESS 1100
123 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1087
124 DEHYDRATION 1083
125 CONFUSIONAL STATE 1063
126 ARTHRITIS 1034
127 FLUID RETENTION 1024
128 BLOOD GLUCOSE INCREASED 1019
129 ATRIAL FIBRILLATION 1018
130 DRY SKIN 1018
131 DRUG INTOLERANCE 1017
132 ANGER 1011
133 DYSPHAGIA 1001
134 RASH ERYTHEMATOUS 996
135 INJECTION SITE ERYTHEMA 995
136 ACUTE KIDNEY INJURY 994
137 CARDIAC DISORDER 993
138 IRRITABILITY 988
139 MUSCULAR WEAKNESS 986
140 ECZEMA 983
141 DIABETES MELLITUS 957
142 PSORIASIS 938
143 AGITATION 919
144 INTENTIONAL PRODUCT MISUSE 916
145 RHINITIS ALLERGIC 913
146 ABDOMINAL DISTENSION 907
147 CEREBROVASCULAR ACCIDENT 905
148 BURNING SENSATION 904
149 DRY MOUTH 901
150 THROAT IRRITATION 897
151 INFLUENZA LIKE ILLNESS 895
152 HALLUCINATION 892
153 CRYING 886
154 FOOD ALLERGY 886
155 EOSINOPHILIA 880
156 FORCED EXPIRATORY VOLUME DECREASED 872
157 VISUAL IMPAIRMENT 859
158 CARDIAC FAILURE CONGESTIVE 858
159 EPISTAXIS 858
160 NO ADVERSE EVENT 847
161 INFUSION RELATED REACTION 835
162 NEUROPATHY PERIPHERAL 835
163 MYOCARDIAL INFARCTION 829
164 EAR INFECTION 825
165 NASAL POLYPS 822
166 DEPRESSED MOOD 818
167 TACHYCARDIA 811
168 SWELLING FACE 810
169 MUSCULOSKELETAL STIFFNESS 809
170 UPPER-AIRWAY COUGH SYNDROME 804
171 SNEEZING 800
172 NECK PAIN 789
173 DISCOMFORT 788
174 VIRAL INFECTION 787
175 SINUS DISORDER 786
176 BALANCE DISORDER 785
177 EMOTIONAL DISTRESS 784
178 EXPOSURE DURING PREGNANCY 783
179 CATARACT 776
180 GASTROINTESTINAL DISORDER 776
181 EYE PRURITUS 770
182 THROMBOSIS 767
183 OSTEOPOROSIS 766
184 SYNCOPE 765
185 GENERAL PHYSICAL HEALTH DETERIORATION 760
186 HAEMOPTYSIS 759
187 BLOOD PRESSURE DECREASED 753
188 RESPIRATORY DISORDER 748
189 SEPSIS 740
190 INJURY 732
191 MOOD SWINGS 723
192 DEEP VEIN THROMBOSIS 721
193 OSTEOARTHRITIS 721
194 HYPOTHYROIDISM 720
195 IMMUNODEFICIENCY 717
196 RESPIRATORY TRACT CONGESTION 710
197 FEELING HOT 705
198 HOT FLUSH 704
199 HERPES ZOSTER 701
200 INJECTION SITE BRUISING 701
201 EYE PAIN 699
202 DRUG INTERACTION 692
203 FIBROMYALGIA 690
204 INTENTIONAL PRODUCT USE ISSUE 689
205 TYPE 2 DIABETES MELLITUS 682
206 DISTURBANCE IN ATTENTION 681
207 AMNESIA 678
208 INJECTION SITE SWELLING 676
209 MOOD ALTERED 674
210 BREATH SOUNDS ABNORMAL 673
211 BLOOD PRESSURE SYSTOLIC INCREASED 672
212 THERAPEUTIC RESPONSE DECREASED 668
213 BLOOD TEST ABNORMAL 665
214 THROMBOCYTOPENIA 662
215 HYPOXIA 657
216 ADVERSE DRUG REACTION 653
217 BRONCHIECTASIS 653
218 CELLULITIS 653
219 RESPIRATORY FAILURE 652
220 DERMATITIS ATOPIC 645
221 SUICIDE ATTEMPT 645
222 VERTIGO 642
223 DRY EYE 641
224 SEIZURE 641
225 HAEMOGLOBIN DECREASED 640
226 NERVOUSNESS 636
227 ADVERSE EVENT 634
228 ILL-DEFINED DISORDER 632
229 INJECTION SITE PRURITUS 630
230 MOBILITY DECREASED 630
231 EOSINOPHIL COUNT INCREASED 619
232 SKIN EXFOLIATION 619
233 MULTIPLE ALLERGIES 617
234 BURSITIS 615
235 UNEVALUABLE EVENT 608
236 NEPHROLITHIASIS 605
237 RASH PRURITIC 605
238 DYSGEUSIA 601
239 SPEECH DISORDER 599
240 PANIC ATTACK 597
241 BLOOD POTASSIUM DECREASED 596
242 PRESCRIBED OVERDOSE 595
243 WHITE BLOOD CELL COUNT DECREASED 591
244 SURGERY 588
245 ANGIOEDEMA 578
246 LACRIMATION INCREASED 575
247 ALLERGIC GRANULOMATOUS ANGIITIS 564
248 BONE PAIN 559
249 CHOLELITHIASIS 557
250 EYE SWELLING 556
251 BLOOD IMMUNOGLOBULIN E INCREASED 555
252 HAEMORRHAGE 552
253 SECRETION DISCHARGE 550
254 MUSCULOSKELETAL PAIN 547
255 PULMONARY MASS 542
256 COELIAC DISEASE 537
257 ABNORMAL DREAMS 534
258 MENTAL DISORDER 531
259 RENAL DISORDER 528
260 FEAR 525
261 BLOOD CHOLESTEROL INCREASED 524
262 SINUS CONGESTION 523
263 IMPAIRED QUALITY OF LIFE 516
264 THERAPEUTIC RESPONSE UNEXPECTED 515
265 EYE IRRITATION 513
266 LETHARGY 508
267 PHARMACEUTICAL PRODUCT COMPLAINT 506
268 THROAT TIGHTNESS 501
269 RHINITIS 500
270 FUNGAL INFECTION 498
271 OCULAR HYPERAEMIA 497
272 PLATELET COUNT DECREASED 494
273 TEMPERATURE REGULATION DISORDER 494
274 EAR PAIN 488
275 VASCULITIS 486
276 PRODUCT DOSE OMISSION 482
277 TINNITUS 480
278 CARPAL TUNNEL SYNDROME 476
279 CONVULSION 476
280 CYSTITIS 473
281 PLEURAL EFFUSION 471
282 ROAD TRAFFIC ACCIDENT 471
283 BRONCHOSPASM 469
284 CONTRAINDICATED PRODUCT ADMINISTERED 469
285 RALES 465
286 FLATULENCE 464
287 GASTROINTESTINAL HAEMORRHAGE 460
288 STAPHYLOCOCCAL INFECTION 454
289 POOR QUALITY SLEEP 451
290 TREATMENT FAILURE 451
291 INJECTION SITE REACTION 450
292 BLISTER 445
293 ARTHROPATHY 439
294 SKIN LESION 438
295 SLEEP TERROR 436
296 INFLAMMATION 434
297 BLOOD CREATININE INCREASED 433
298 APHONIA 432
299 EMOTIONAL DISORDER 432
300 PULMONARY FIBROSIS 432
301 CARDIAC FAILURE 427
302 INJECTION SITE HAEMORRHAGE 425
303 MATERNAL EXPOSURE DURING PREGNANCY 424
304 CHRONIC SINUSITIS 423
305 WHITE BLOOD CELL COUNT INCREASED 422
306 OBESITY 421
307 LYMPHADENOPATHY 416
308 LIMB INJURY 415
309 PANCREATITIS 413
310 PULMONARY FUNCTION TEST ABNORMAL 411
311 ACCIDENTAL EXPOSURE TO PRODUCT 409
312 GASTROENTERITIS VIRAL 409
313 DISEASE RECURRENCE 407
314 PRODUCT SUBSTITUTION ISSUE 402
315 RESTLESSNESS 399
316 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 398
317 DEVICE MALFUNCTION 395
318 INTERVERTEBRAL DISC PROTRUSION 393
319 STOMATITIS 391
320 HEART RATE DECREASED 390
321 THERAPEUTIC RESPONSE SHORTENED 389
322 DEVICE ISSUE 388
323 LUNG INFECTION 386
324 EYE DISORDER 384
325 TRANSIENT ISCHAEMIC ATTACK 384
326 RASH MACULAR 383
327 RIB FRACTURE 383
328 INFUSION SITE PAIN 382
329 NIGHT SWEATS 382
330 THERAPY INTERRUPTED 382
331 RENAL IMPAIRMENT 381
332 EMPHYSEMA 375
333 KIDNEY INFECTION 374
334 JOINT INJURY 373
335 ACNE 369
336 RESPIRATORY DISTRESS 364
337 SKIN DISCOLOURATION 363
338 LIMB DISCOMFORT 361
339 POLLAKIURIA 360
340 RESPIRATORY RATE INCREASED 359
341 TREATMENT NONCOMPLIANCE 358
342 BODY TEMPERATURE DECREASED 357
343 LIP SWELLING 356
344 DIVERTICULITIS 354
345 UPPER LIMB FRACTURE 354
346 UNDERDOSE 352
347 HYPERGLYCAEMIA 350
348 CANDIDA INFECTION 348
349 HYPERSOMNIA 348
350 SWOLLEN TONGUE 348
351 CARDIAC ARREST 347
352 PULMONARY CONGESTION 346
353 THINKING ABNORMAL 346
354 PULMONARY OEDEMA 345
355 SENSITIVITY TO WEATHER CHANGE 344
356 FOOT FRACTURE 343
357 HIATUS HERNIA 339
358 RETCHING 339
359 PSYCHOMOTOR HYPERACTIVITY 338
360 HAEMATOCHEZIA 336
361 HEAD INJURY 335
362 ORAL CANDIDIASIS 335
363 ALANINE AMINOTRANSFERASE INCREASED 334
364 CHEST X-RAY ABNORMAL 334
365 GOUT 334
366 PULMONARY FUNCTION TEST DECREASED 332
367 DISEASE PROGRESSION 331
368 PSYCHOTIC DISORDER 329
369 NEURALGIA 328
370 ASTHMATIC CRISIS 327
371 DRUG EFFECT DECREASED 327
372 CORONARY ARTERY DISEASE 325
373 DYSURIA 322
374 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 322
375 INFUSION SITE ERYTHEMA 322
376 INSURANCE ISSUE 322
377 PRODUCT DOSE OMISSION IN ERROR 322
378 GASTRIC DISORDER 321
379 BREAST CANCER 320
380 BLOOD GLUCOSE DECREASED 319
381 POLYCYSTIC OVARIES 319
382 ASPARTATE AMINOTRANSFERASE INCREASED 318
383 HYPOACUSIS 318
384 NEUTROPENIA 316
385 NASAL OEDEMA 315
386 ANAPHYLACTIC SHOCK 314
387 RESPIRATORY SYMPTOM 314
388 SKIN BURNING SENSATION 314
389 ARRHYTHMIA 311
390 LUNG NEOPLASM MALIGNANT 311
391 GLAUCOMA 309
392 ANKLE FRACTURE 308
393 PNEUMONITIS 308
394 URINARY INCONTINENCE 307
395 GASTRITIS 306
396 NEUROPSYCHOLOGICAL SYMPTOMS 304
397 CARDIAC MURMUR 303
398 FOETAL DEATH 303
399 DISORIENTATION 302
400 INTESTINAL OBSTRUCTION 302
401 RECTAL HAEMORRHAGE 302
402 INJECTION SITE RASH 300
403 PAIN IN JAW 300
404 MEDICATION ERROR 298
405 OBSESSIVE-COMPULSIVE DISORDER 298
406 EAR PRURITUS 297
407 INTERVERTEBRAL DISC DEGENERATION 297
408 PHOTOPHOBIA 297
409 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 295
410 SKIN DISORDER 294
411 CHOKING 292
412 GAIT INABILITY 291
413 COGNITIVE DISORDER 290
414 BRONCHIAL SECRETION RETENTION 289
415 HEART RATE IRREGULAR 289
416 PRE-EXISTING CONDITION IMPROVED 289
417 THERAPY CESSATION 289
418 CROHN^S DISEASE 287
419 END STAGE RENAL DISEASE 287
420 INTENTIONAL SELF-INJURY 287
421 HYPONATRAEMIA 286
422 ANGINA PECTORIS 284
423 HYPOGLYCAEMIA 284
424 RESTLESS LEGS SYNDROME 283
425 IRRITABLE BOWEL SYNDROME 282
426 MUSCULOSKELETAL CHEST PAIN 282
427 PHARYNGITIS STREPTOCOCCAL 282
428 PROCEDURAL PAIN 282
429 TIC 282
430 ACUTE RESPIRATORY FAILURE 281
431 INTENTIONAL DOSE OMISSION 281
432 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 280
433 PARANOIA 280
434 HYPOKALAEMIA 279
435 INTERSTITIAL LUNG DISEASE 279
436 ORAL PAIN 279
437 GALLBLADDER DISORDER 278
438 MOVEMENT DISORDER 278
439 DYSARTHRIA 277
440 CONJUNCTIVITIS 276
441 SCREAMING 276
442 COMPLETED SUICIDE 275
443 MULTIPLE SCLEROSIS RELAPSE 275
444 PLATELET COUNT INCREASED 275
445 AFFECTIVE DISORDER 274
446 DRUG EXPOSURE DURING PREGNANCY 274
447 BACTERIAL INFECTION 272
448 LIGAMENT SPRAIN 272
449 WRONG TECHNIQUE IN DRUG USAGE PROCESS 271
450 EATING DISORDER 267
451 DYSKINESIA 266
452 AGEUSIA 265
453 INFUSION SITE SWELLING 265
454 LOCALISED INFECTION 264
455 DYSSTASIA 262
456 LARYNGITIS 261
457 RESPIRATION ABNORMAL 260
458 DRUG ADMINISTRATION ERROR 259
459 THROAT CLEARING 258
460 EXPOSURE VIA SKIN CONTACT 257
461 ROTATOR CUFF SYNDROME 256
462 MUSCULOSKELETAL DISCOMFORT 255
463 HEREDITARY ANGIOEDEMA 254
464 SENSITISATION 254
465 THERAPEUTIC PRODUCT EFFECT DECREASED 254
466 DERMATITIS CONTACT 253
467 ANOSMIA 252
468 BLOOD PRESSURE ABNORMAL 252
469 DUST ALLERGY 252
470 FEELING COLD 249
471 HAEMATOMA 249
472 ANHEDONIA 248
473 EAR DISCOMFORT 247
474 PRURITUS GENERALISED 247
475 ATELECTASIS 246
476 INJECTION SITE URTICARIA 246
477 MAJOR DEPRESSION 246
478 DRUG DEPENDENCE 245
479 FEELING JITTERY 245
480 PHARYNGITIS 245
481 PRESYNCOPE 244
482 PULMONARY HYPERTENSION 244
483 NEUROPSYCHIATRIC SYMPTOMS 243
484 PSORIATIC ARTHROPATHY 242
485 ASPIRATION 241
486 PERSONALITY CHANGE 241
487 WITHDRAWAL SYNDROME 239
488 HYPERLIPIDAEMIA 237
489 PRODUCT ADMINISTRATION INTERRUPTED 237
490 VITAMIN D DEFICIENCY 237
491 MUSCLE TWITCHING 236
492 NEOPLASM MALIGNANT 236
493 RENAL FAILURE ACUTE 236
494 RENAL INJURY 236
495 WOUND 236
496 BRADYCARDIA 235
497 OSTEOPENIA 235
498 BACK DISORDER 234
499 WRIST FRACTURE 234
500 DECREASED ACTIVITY 233
501 ORAL HERPES 233
502 APHASIA 231
503 PHARYNGEAL OEDEMA 231
504 CLOSTRIDIUM DIFFICILE INFECTION 229
505 HEPATIC STEATOSIS 229
506 PARAESTHESIA ORAL 229
507 RED BLOOD CELL COUNT DECREASED 229
508 SARCOIDOSIS 228
509 SOMNAMBULISM 228
510 BODY TEMPERATURE INCREASED 227
511 HALLUCINATION, AUDITORY 227
512 TOOTH DISORDER 227
513 MULTIPLE SCLEROSIS 224
514 OBSTRUCTION 223
515 BIPOLAR DISORDER 222
516 BLOOD LACTIC ACID INCREASED 221
517 POST PROCEDURAL COMPLICATION 221
518 THERAPY NON-RESPONDER 221
519 TOOTH INFECTION 220
520 BRONCHIAL WALL THICKENING 219
521 INJECTION SITE MASS 219
522 REVERSIBLE AIRWAYS OBSTRUCTION 219
523 IMPAIRED WORK ABILITY 218
524 BONE DISORDER 217
525 DIPLOPIA 217
526 TOOTH ABSCESS 217
527 BLOOD PRESSURE FLUCTUATION 216
528 CHOLECYSTITIS CHRONIC 216
529 CYSTIC FIBROSIS 216
530 PHOTOSENSITIVITY REACTION 216
531 QUALITY OF LIFE DECREASED 216
532 SKIN LACERATION 216
533 URINARY RETENTION 216
534 TENDERNESS 215
535 BLINDNESS 214
536 SYSTEMIC LUPUS ERYTHEMATOSUS 214
537 THIRST 214
538 HALLUCINATION, VISUAL 213
539 RASH GENERALISED 213
540 HIP FRACTURE 211
541 SCRATCH 211
542 TEMPERATURE INTOLERANCE 211
543 TOOTHACHE 211
544 CARDIOMEGALY 210
545 COLITIS 210
546 DRUG EFFECT INCOMPLETE 210
547 LIVER DISORDER 210
548 RESPIRATORY SYNCYTIAL VIRUS INFECTION 210
549 NODULE 207
550 RESTRICTIVE PULMONARY DISEASE 207
551 ADRENAL INSUFFICIENCY 205
552 IMPAIRED HEALING 205
553 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 204
554 DRUG WITHDRAWAL SYNDROME 203
555 HERNIA 203
556 VAGINAL HAEMORRHAGE 203
557 ARTERIOSCLEROSIS CORONARY ARTERY 202
558 FEMUR FRACTURE 202
559 HYPOVENTILATION 202
560 PRODUCT AVAILABILITY ISSUE 202
561 BLOOD BILIRUBIN INCREASED 201
562 GLOSSODYNIA 201
563 PALLOR 201
564 PHARYNGEAL SWELLING 201
565 JOINT STIFFNESS 200
566 KNEE ARTHROPLASTY 200
567 SCIATICA 200
568 VITAL CAPACITY DECREASED 200
569 DISABILITY 199
570 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 198
571 PNEUMONIA BACTERIAL 198
572 TOXICITY TO VARIOUS AGENTS 198
573 BLOOD SODIUM DECREASED 197
574 MENTAL STATUS CHANGES 197
575 SKIN FISSURES 197
576 ACTIVITIES OF DAILY LIVING IMPAIRED 196
577 CONCUSSION 196
578 CHOLECYSTECTOMY 195
579 DRUG DOSE OMISSION BY DEVICE 195
580 GASTROENTERITIS 195
581 LIVER FUNCTION TEST INCREASED 195
582 TENDONITIS 195
583 EJECTION FRACTION 194
584 FLANK PAIN 194
585 PNEUMOTHORAX 194
586 DEAFNESS 193
587 OROPHARYNGEAL DISCOMFORT 193
588 ECONOMIC PROBLEM 191
589 EYE INFECTION 191
590 HAEMATOCRIT DECREASED 191
591 HAEMATURIA 191
592 ARTERIOSCLEROSIS 189
593 INITIAL INSOMNIA 189
594 IMPAIRED GASTRIC EMPTYING 188
595 PERICARDIAL EFFUSION 188
596 SOCIAL AVOIDANT BEHAVIOUR 188
597 CONJUNCTIVITIS ALLERGIC 187
598 SPINAL FRACTURE 187
599 TRANSAMINASES INCREASED 187
600 BRAIN FOG 186
601 COLD SWEAT 186
602 INFUSION SITE PRURITUS 186
603 RHONCHI 185
604 SPUTUM INCREASED 185
605 LIVER FUNCTION TEST ABNORMAL 184
606 SCAR 184
607 BRONCHIAL OBSTRUCTION 183
608 CARDIOMYOPATHY 183
609 TOTAL LUNG CAPACITY DECREASED 183
610 OCULAR DISCOMFORT 182
611 SKIN HAEMORRHAGE 181
612 ABORTION SPONTANEOUS 180
613 LOWER LIMB FRACTURE 180
614 SARS-COV-2 TEST POSITIVE 180
615 SKIN IRRITATION 180
616 ABASIA 177
617 BACK INJURY 177
618 HEAD DISCOMFORT 177
619 THYROID DISORDER 177
620 BENIGN PROSTATIC HYPERPLASIA 176
621 DRY THROAT 176
622 EXTRA DOSE ADMINISTERED 176
623 MUSCLE TIGHTNESS 176
624 BLOOD CALCIUM INCREASED 175
625 CARDIO-RESPIRATORY ARREST 175
626 HAEMORRHOIDS 175
627 WEIGHT FLUCTUATION 175
628 POLYP 174
629 SKIN PLAQUE 174
630 FRUSTRATION TOLERANCE DECREASED 173
631 PNEUMONIA ASPIRATION 173
632 SINUS TACHYCARDIA 173
633 SPIROMETRY ABNORMAL 173
634 PRODUCT STORAGE ERROR 172
635 SPINAL OSTEOARTHRITIS 172
636 ABSCESS 171
637 LABORATORY TEST ABNORMAL 171
638 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 171
639 INCREASED APPETITE 170
640 SKIN ULCER 170
641 BLOOD IRON DECREASED 169
642 BLOOD URINE PRESENT 169
643 BRONCHIAL HYPERREACTIVITY 169
644 FEEDING DISORDER 169
645 NERVOUS SYSTEM DISORDER 169
646 COLITIS ULCERATIVE 168
647 DEPRESSED LEVEL OF CONSCIOUSNESS 168
648 POST-TRAUMATIC STRESS DISORDER 168
649 PSEUDOMONAS INFECTION 168
650 CHROMATURIA 167
651 FAECES DISCOLOURED 166
652 HYPERCHOLESTEROLAEMIA 166
653 NEEDLE ISSUE 166
654 NEUTROPHIL COUNT DECREASED 166
655 FACIAL PAIN 165
656 DENTAL CARIES 164
657 DIASTOLIC DYSFUNCTION 164
658 EPILEPSY 164
659 DERMATITIS 163
660 IMMUNE SYSTEM DISORDER 163
661 NASAL DISCHARGE DISCOLOURATION 163
662 HYPERKALAEMIA 162
663 HYPOPHAGIA 162
664 LEUKOPENIA 162
665 NEUROLOGICAL SYMPTOM 162
666 PLASMA CELL MYELOMA 162
667 FULL BLOOD COUNT DECREASED 161
668 INCREASED UPPER AIRWAY SECRETION 161
669 SENSORY DISTURBANCE 161
670 APPETITE DISORDER 160
671 ARTHROPOD BITE 160
672 DEVICE DELIVERY SYSTEM ISSUE 160
673 NEURITIS 160
674 LOCAL SWELLING 159
675 PULMONARY ALVEOLAR HAEMORRHAGE 159
676 COMA 158
677 DYSPHEMIA 158
678 INTERNATIONAL NORMALISED RATIO INCREASED 158
679 TOTAL LUNG CAPACITY INCREASED 158
680 BLOOD ALKALINE PHOSPHATASE INCREASED 157
681 CHRONIC SPONTANEOUS URTICARIA 157
682 HYSTERECTOMY 157
683 MITRAL VALVE INCOMPETENCE 157
684 OBSTRUCTIVE SLEEP APNOEA SYNDROME 157
685 RASH PAPULAR 157
686 SNORING 157
687 VISUAL ACUITY REDUCED 157
688 CYANOSIS 156
689 DEMENTIA 156
690 PULMONARY THROMBOSIS 156
691 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 155
692 MYCOTIC ALLERGY 155
693 SELF-INJURIOUS IDEATION 155
694 BODY HEIGHT DECREASED 154
695 SEPTIC SHOCK 154
696 INFUSION SITE HAEMORRHAGE 153
697 CANDIDIASIS 152
698 MENTAL IMPAIRMENT 152
699 EXPIRED PRODUCT ADMINISTERED 151
700 GASTRIC ULCER 151
701 HEPATIC FUNCTION ABNORMAL 151
702 IRON DEFICIENCY ANAEMIA 151
703 LEUKOCYTOSIS 151
704 PARANASAL SINUS DISCOMFORT 151
705 SINUS HEADACHE 150
706 NASAL DISCOMFORT 149
707 ULCER 149
708 LUNG INFILTRATION 148
709 NEPHROGENIC ANAEMIA 148
710 BONE DENSITY DECREASED 147
711 EXERCISE TOLERANCE DECREASED 147
712 TASTE DISORDER 147
713 ATTENTION DEFICIT HYPERACTIVITY DISORDER 146
714 DIZZINESS POSTURAL 146
715 PERFUME SENSITIVITY 146
716 PULMONARY VASCULITIS 146
717 SKIN INFECTION 146
718 GLYCOSYLATED HAEMOGLOBIN INCREASED 145
719 MITE ALLERGY 145
720 MOUTH ULCERATION 145
721 PANCYTOPENIA 145
722 NERVE COMPRESSION 144
723 RESPIRATORY ARREST 144
724 LUNG OPACITY 143
725 ALLERGY TO ANIMAL 142
726 DEVICE BREAKAGE 142
727 INJECTION SITE WARMTH 142
728 JOINT DISLOCATION 142
729 APATHY 141
730 INFUSION SITE DISCHARGE 141
731 NERVE INJURY 141
732 SCHIZOPHRENIA 141
733 SPINAL OPERATION 141
734 DEVICE DISLOCATION 140
735 INCREASED TENDENCY TO BRUISE 140
736 PERIPHERAL COLDNESS 140
737 C-REACTIVE PROTEIN INCREASED 138
738 CHOKING SENSATION 138
739 OSTEONECROSIS 138
740 SCAB 138
741 WOUND INFECTION 138
742 ACCIDENTAL OVERDOSE 137
743 ACUTE MYOCARDIAL INFARCTION 137
744 BLOOD MAGNESIUM DECREASED 137
745 BLOOD TRIGLYCERIDES INCREASED 137
746 DYSPNOEA AT REST 136
747 ENURESIS 136
748 LUNG HYPERINFLATION 136
749 PARALYSIS 136
750 EXOSTOSIS 135
751 PRODUCT PRESCRIBING ERROR 135
752 BRONCHITIS CHRONIC 134
753 DIVERTICULUM 134
754 FREQUENT BOWEL MOVEMENTS 134
755 MACULAR DEGENERATION 134
756 ORAL DISCOMFORT 134
757 PAIN OF SKIN 134
758 DERMATITIS ALLERGIC 133
759 FACE OEDEMA 133
760 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 132
761 MALIGNANT NEOPLASM PROGRESSION 132
762 MULTIPLE FRACTURES 132
763 NOCTURIA 132
764 ELECTROCARDIOGRAM QT PROLONGED 131
765 EYE DISCHARGE 131
766 HYPOAESTHESIA ORAL 131
767 HYPOKINESIA 131
768 INTENTIONAL OVERDOSE 131
769 HYPERVENTILATION 130
770 JAUNDICE 130
771 UNRESPONSIVE TO STIMULI 130
772 VITAMIN D DECREASED 130
773 ACCIDENT 129
774 DECREASED IMMUNE RESPONSIVENESS 129
775 HAIR TEXTURE ABNORMAL 129
776 HEPATITIS 129
777 MUSCLE STRAIN 129
778 CYST 128
779 EDUCATIONAL PROBLEM 128
780 FOETAL EXPOSURE DURING PREGNANCY 128
781 PRODUCT TASTE ABNORMAL 127
782 TRICUSPID VALVE INCOMPETENCE 127
783 TUBULOINTERSTITIAL NEPHRITIS 127
784 ABDOMINAL PAIN LOWER 126
785 CREPITATIONS 126
786 ERUCTATION 126
787 OVARIAN CYST 126
788 INFUSION SITE BRUISING 125
789 MANIA 125
790 VOCAL CORD DYSFUNCTION 125
791 CEREBRAL HAEMORRHAGE 124
792 HAND FRACTURE 124
793 MASS 124
794 COAGULOPATHY 123
795 ECCHYMOSIS 123
796 FEBRILE NEUTROPENIA 123
797 NASAL OBSTRUCTION 123
798 PLEURITIC PAIN 123
799 TOOTH FRACTURE 123
800 DEVICE FAILURE 122
801 HAEMATEMESIS 122
802 INCORRECT DRUG ADMINISTRATION DURATION 122
803 AFFECT LABILITY 121
804 BLOOD GLUCOSE ABNORMAL 121
805 CORONARY ARTERY OCCLUSION 121
806 DECREASED INTEREST 121
807 DIABETES MELLITUS INADEQUATE CONTROL 121
808 OSTEOMYELITIS 121
809 HEPATOTOXICITY 120
810 MAST CELL ACTIVATION SYNDROME 120
811 MENISCUS INJURY 120
812 VIRAL UPPER RESPIRATORY TRACT INFECTION 120
813 COVID-19 PNEUMONIA 119
814 HUNGER 119
815 ORTHOSTATIC HYPOTENSION 119
816 PRODUCT PRESCRIBING ISSUE 119
817 TOTAL LUNG CAPACITY ABNORMAL 119
818 DEVICE LEAKAGE 118
819 HOMICIDAL IDEATION 118
820 NORMOCHROMIC NORMOCYTIC ANAEMIA 118
821 POOR VENOUS ACCESS 118
822 PRODUCT DISTRIBUTION ISSUE 118
823 MICTURITION URGENCY 117
824 PETECHIAE 117
825 PRODUCT ADMINISTRATION ERROR 117
826 PROLONGED EXPIRATION 117
827 BLOOD UREA INCREASED 116
828 DELIRIUM 116
829 SEDATION 116
830 SYMPTOM RECURRENCE 116
831 APPLICATION SITE ERYTHEMA 115
832 GLUCOSE TOLERANCE IMPAIRED 115
833 INCORRECT ROUTE OF DRUG ADMINISTRATION 115
834 INFUSION SITE EXTRAVASATION 115
835 PANCREATITIS ACUTE 115
836 SKIN CANCER 115
837 SUICIDAL BEHAVIOUR 115
838 SUPRAVENTRICULAR TACHYCARDIA 115
839 BLOOD CREATINE PHOSPHOKINASE INCREASED 114
840 INTENTIONAL DRUG MISUSE 114
841 MENORRHAGIA 114
842 TENDON RUPTURE 114
843 BLOOD PRESSURE DIASTOLIC DECREASED 113
844 CHOLECYSTITIS 113
845 EOSINOPHIL COUNT ABNORMAL 113
846 FOOT DEFORMITY 113
847 GENERALISED ANXIETY DISORDER 113
848 INCREASED BRONCHIAL SECRETION 113
849 LOWER RESPIRATORY TRACT CONGESTION 113
850 RHABDOMYOLYSIS 113
851 BASAL CELL CARCINOMA 112
852 CUSHINGOID 112
853 DIABETIC NEUROPATHY 112
854 DYSLIPIDAEMIA 112
855 FORCED VITAL CAPACITY DECREASED 112
856 HAIR COLOUR CHANGES 112
857 MUSCULOSKELETAL DISORDER 112
858 AUTOIMMUNE DISORDER 111
859 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 111
860 PANIC REACTION 111
861 ANOREXIA 110
862 BRONCHIAL DISORDER 110
863 CARDIOVASCULAR DISORDER 110
864 NEPHROPATHY 110
865 OVERWEIGHT 110
866 RENAL CYST 110
867 SJOGREN^S SYNDROME 110
868 COORDINATION ABNORMAL 109
869 EYE HAEMORRHAGE 109
870 HYPERTHYROIDISM 109
871 INCORRECT PRODUCT ADMINISTRATION DURATION 109
872 SCOLIOSIS 109
873 TARDIVE DYSKINESIA 109
874 THERAPY PARTIAL RESPONDER 109
875 VENTRICULAR EXTRASYSTOLES 109
876 PELVIC PAIN 108
877 SINUS OPERATION 108
878 SPUTUM CULTURE POSITIVE 108
879 FRACTURE 107
880 HIP ARTHROPLASTY 107
881 HYPOCALCAEMIA 107
882 JAUNDICE CHOLESTATIC 107
883 SINUS PAIN 107
884 VENTRICULAR TACHYCARDIA 107
885 DEPRESSIVE SYMPTOM 106
886 DRUG ABUSE 106
887 FORMICATION 106
888 NASAL DISORDER 105
889 PAROSMIA 105
890 PLEURISY 105
891 EAR DISORDER 104
892 MENSTRUATION IRREGULAR 104
893 PREGNANCY 104
894 PRODUCT PREPARATION ERROR 104
895 PSYCHOLOGICAL TRAUMA 104
896 BLOOD POTASSIUM INCREASED 103
897 BRUXISM 103
898 GASTROINTESTINAL INFECTION 103
899 PROSTATE CANCER 103
900 SKIN REACTION 103
901 DEVICE USE ERROR 102
902 DRUG EFFECT LESS THAN EXPECTED 102
903 DRUG-INDUCED LIVER INJURY 102
904 HYPOMANIA 102
905 INJECTION SITE HAEMATOMA 102
906 LACERATION 102
907 PNEUMONIA VIRAL 102
908 PULMONARY PAIN 102
909 SPINAL DISORDER 102
910 OESOPHAGITIS 101
911 POOR QUALITY DEVICE USED 101
912 PRODUCT ADHESION ISSUE 101
913 SENSATION OF FOREIGN BODY 101
914 AORTIC VALVE STENOSIS 100
915 DRUG ERUPTION 100
916 DRUG PRESCRIBING ERROR 100
917 HEPATIC CIRRHOSIS 100
918 LARYNGEAL STENOSIS 100
919 SMALL INTESTINAL OBSTRUCTION 100
920 BLADDER DISORDER 99
921 BLOOD PRESSURE DIASTOLIC INCREASED 99
922 EYELID OEDEMA 99
923 HEPATOMEGALY 99
924 PAPULE 99
925 REBOUND ACID HYPERSECRETION 99
926 GENERALISED OEDEMA 98
927 INCONTINENCE 98
928 PRODUCT PHYSICAL ISSUE 98
929 SKIN SWELLING 98
930 FEELING OF DESPAIR 97
931 IRON DEFICIENCY 97
932 PARKINSON^S DISEASE 97
933 ANXIETY DISORDER 96
934 ERECTILE DYSFUNCTION 96
935 RIGHT VENTRICULAR HYPERTROPHY 96
936 TACHYPNOEA 96
937 BREAST MASS 95
938 DEVICE EXPULSION 95
939 GRAND MAL CONVULSION 95
940 HEMIPARESIS 95
941 IMPAIRED DRIVING ABILITY 95
942 KNEE OPERATION 95
943 POST PROCEDURAL INFECTION 95
944 SKIN ABRASION 95
945 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 95
946 ADVERSE REACTION 94
947 ASCITES 94
948 DEVICE RELATED INFECTION 94
949 DRUG DISPENSING ERROR 94
950 INJECTION SITE DISCOMFORT 94
951 MELAENA 94
952 MUSCLE DISORDER 94
953 SKIN ATROPHY 94
954 SKIN WARM 94
955 AMENORRHOEA 93
956 EYE INFLAMMATION 93
957 JOINT RANGE OF MOTION DECREASED 93
958 SLUGGISHNESS 93
959 SPINAL COMPRESSION FRACTURE 93
960 SWELLING OF EYELID 93
961 COMPLICATION ASSOCIATED WITH DEVICE 92
962 GASTROINTESTINAL PAIN 92
963 PARANASAL SINUS HYPERSECRETION 92
964 TERMINAL INSOMNIA 92
965 EJECTION FRACTION DECREASED 91
966 HOSTILITY 91
967 HYPOGAMMAGLOBULINAEMIA 91
968 PHARYNGOLARYNGEAL PAIN 91
969 BLOOD CALCIUM DECREASED 90
970 IMMUNOSUPPRESSION 90
971 INJECTION SITE DISCOLOURATION 90
972 INTRAOCULAR PRESSURE INCREASED 90
973 LEFT VENTRICULAR HYPERTROPHY 90
974 NASAL DRYNESS 90
975 NEUTROPHIL COUNT INCREASED 90
976 RHINOVIRUS INFECTION 90
977 RIGHT ATRIAL HYPERTROPHY 90
978 BLOOD LACTATE DEHYDROGENASE INCREASED 89
979 ENCEPHALOPATHY 89
980 METABOLIC ACIDOSIS 89
981 PRODUCT USE COMPLAINT 89
982 SELF ESTEEM DECREASED 89
983 STREPTOCOCCAL INFECTION 89
984 ABDOMINAL TENDERNESS 88
985 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 88
986 BLOOD GLUCOSE FLUCTUATION 88
987 CONCOMITANT DISEASE AGGRAVATED 88
988 ESSENTIAL HYPERTENSION 88
989 GINGIVAL BLEEDING 88
990 NASAL SEPTUM DEVIATION 88
991 SPINAL PAIN 88
992 TOOTH EXTRACTION 88
993 HAIR DISORDER 87
994 INJECTION SITE IRRITATION 87
995 UPPER RESPIRATORY TRACT CONGESTION 87
996 UTERINE LEIOMYOMA 87
997 APPLICATION SITE PAIN 86
998 GROIN PAIN 85
999 OSTEONECROSIS OF JAW 85